| Literature DB >> 28947419 |
Dylan Z Kelley1, Emily L Flam1, Evgeny Izumchenko1, Ludmila V Danilova2,3, Hildegard A Wulf1, Theresa Guo1, Dzov A Singman1, Bahman Afsari2, Alyza M Skaist2, Michael Considine2, Jane A Welch4,5, Elena Stavrovskaya6,7, Justin A Bishop5, William H Westra5, Zubair Khan1, Wayne M Koch1, David Sidransky1, Sarah J Wheelan2, Joseph A Califano8,9, Alexander V Favorov2,3,10, Elana J Fertig2, Daria A Gaykalova11.
Abstract
Chromatin alterations mediate mutations and gene expression changes in cancer. Chromatin immunoprecipitation followed by sequencing (ChIP-Seq) has been utilized to study genome-wide chromatin structure in human cancer cell lines, yet numerous technical challenges limit comparable analyses in primary tumors. Here we have developed a new whole-genome analytic pipeline to optimize ChIP-Seq protocols on patient-derived xenografts from human papillomavirus-related (HPV+) head and neck squamous cell carcinoma (HNSCC) samples. We further associated chromatin aberrations with gene expression changes from a larger cohort of the tumor and normal samples with RNA-Seq data. We detect differential histone enrichment associated with tumor-specific gene expression variation, sites of HPV integration in the human genome, and HPV-associated histone enrichment sites upstream of cancer driver genes, which play central roles in cancer-associated pathways. These comprehensive analyses enable unprecedented characterization of the complex network of molecular changes resulting from chromatin alterations that drive HPV-related tumorigenesis. Cancer Res; 77(23); 6538-50. ©2017 AACR. ©2017 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28947419 PMCID: PMC6029614 DOI: 10.1158/0008-5472.CAN-17-0833
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701